{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:59:53Z","timestamp":1780675193906,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"DOI":"10.1007\/s10461-026-05134-1","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:23:13Z","timestamp":1780665793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Feasibility and Acceptability of a Mobile Medical Unit Program\u2014(IFE4Her) to Enhance PrEP Awareness and Access Among Cis-gender Women in Low-Income Southeastern Communities: A Pilot Study"],"prefix":"10.1007","clinical-trial-number":[{"clinical-trial-number":"nct05644834","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"C. E.","family":"Golin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Ayangeakaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. H.","family":"Keshishian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pulliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Woodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Amola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Riggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Lightfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"McKellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"10279","key":"5134_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(21)00396-2","volume":"20","author":"AA Adimora","year":"2021","unstructured":"Adimora AA, Ramirez C, Poteat T, et al. HIV and women in the USA: what we know and where to go from here. Lancet. 2021;20(10279):1107\u201315.","journal-title":"Lancet"},{"key":"5134_CR2","unstructured":"Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2018\u20132022. HIV Surveillance Supplemental Report. 2024.; 29(No. 1).\u00a0https:\/\/www.cdc.gov\/hiv-data\/nhss\/estimated-hiv-incidence-and-prevalence.html. Accessed 22 Feb 2025."},{"issue":"10279","key":"5134_CR3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0140-6736(21)00395-0","volume":"20","author":"PS Sullivan","year":"2021","unstructured":"Sullivan PS, Satcher Johnson A, Pembleton ES, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;20(10279):1095\u2013106.","journal-title":"Lancet"},{"issue":"5","key":"5134_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s10900-017-0325-8","volume":"42","author":"S Reif","year":"2017","unstructured":"Reif S, Safley D, McAllaster C, Wilson E, Whetten K. State of HIV in the US Deep South. J Community Health. 2017;42(5):844\u201353.","journal-title":"J Community Health"},{"key":"5134_CR5","unstructured":"Hess KL, Johnson SD, Hu X et al. Diagnoses of HIV infection in the United States and dependent areas, 2017.\u00a02018."},{"issue":"11","key":"5134_CR6","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1007\/s10461-019-02611-8","volume":"23","author":"MCD Stoner","year":"2019","unstructured":"Stoner MCD, Haley DF, Golin CE, Adimora AA, Pettifor A. The relationship between economic deprivation, housing instability and transactional sex among women in North Carolina (HPTN 064). AIDS Behav. 2019;23(11):2946\u201355.","journal-title":"AIDS Behav"},{"issue":"7","key":"5134_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10461-014-0992-8","volume":"19","author":"J Justman","year":"2015","unstructured":"Justman J, Befus M, Hughes J, et al. Sexual behaviors of US women at risk of HIV acquisition: a longitudinal analysis of findings from HPTN 064. AIDS Behav. 2015;19(7):1327\u201337.","journal-title":"AIDS Behav"},{"issue":"1","key":"5134_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-158-1-201301010-00004","volume":"1","author":"SL Hodder","year":"2013","unstructured":"Hodder SL, Justman J, Hughes JP, et al. HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med. 2013;1(1):10\u20138.","journal-title":"Ann Intern Med"},{"key":"5134_CR9","unstructured":"Prevention. CfDCa. Diagnoses, deaths, and prevalence of HIV in the United States and 6 territories and freely associated states, 2022. HIV Surveillance Report, 2022. 2022; http:\/\/www.cdc.gov\/hiv-data\/nhss\/hiv-diagnoses-deaths-prevalence.html. Accessed 27 Jan 2026."},{"key":"5134_CR10","unstructured":"KFF. The Impact of HIV on Women in the United States. 2024.; https:\/\/www.kff.org\/hivaids\/fact-sheet\/the-impact-of-hiv-on-women-in-the-united-states"},{"issue":"6","key":"5134_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jana.2018.03.005","volume":"29","author":"C Chapman Lambert","year":"2018","unstructured":"Chapman Lambert C, Marrazzo J, Amico KR, Mugavero MJ, Elopre L. PrEParing women to prevent HIV: an integrated theoretical framework to PrEP Black women in the United States. J Assoc Nurses AIDS Care. 2018;29(6):835\u201348.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"5134_CR12","unstructured":"Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent, Areas. 2020. 2020.\u00a0https:\/\/stacks.cdc.gov\/view\/cdc\/121127. Accessed 18 Jul 2022."},{"issue":"5","key":"5134_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"2","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. New Engl J Med. 2012;2(5):399\u2013410.","journal-title":"New Engl J Med"},{"issue":"8","key":"5134_CR14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2023.9865","volume":"330","author":"R Chou","year":"2023","unstructured":"Chou R, Spencer H, Bougatsos C, Blazina I, Ahmed A, Selph S. Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023;330(8):746\u201363.","journal-title":"JAMA"},{"issue":"11","key":"5134_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jama.2024.0464","volume":"331","author":"J Marrazzo","year":"2024","unstructured":"Marrazzo J, Tao L, Becker M, et al. HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women. JAMA. 2024;331(11):930\u20137.","journal-title":"JAMA"},{"issue":"11","key":"5134_CR16","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jama.2024.0432","volume":"331","author":"AN Sheth","year":"2024","unstructured":"Sheth AN, Momplaisir F, Dumond JB. Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women. JAMA. 2024;331(11):912\u20134.","journal-title":"JAMA"},{"issue":"1","key":"5134_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/COH.0000000000000207","volume":"11","author":"KA Thomson","year":"2016","unstructured":"Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women. Curr Opin HIV AIDS. 2016;11(1):18\u201326.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"5134_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/apc.2017.0201","volume":"32","author":"E Aaron","year":"2018","unstructured":"Aaron E, Blum C, Seidman D, et al. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States. AIDS Patient Care STDS. 2018;32(1):16\u201323.","journal-title":"AIDS Patient Care STDS"},{"key":"5134_CR19","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000730","author":"L Goparaju","year":"2017","unstructured":"Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women. J AIDS Clin Res. 2017. https:\/\/doi.org\/10.4172\/2155-6113.1000730.","journal-title":"J AIDS Clin Res"},{"issue":"4","key":"5134_CR20","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10508-020-01903-8","volume":"50","author":"A Baldwin","year":"2021","unstructured":"Baldwin A, Light B, Allison WE. Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature. Arch Sex Behav. 2021;50(4):1713\u201328.","journal-title":"Arch Sex Behav"},{"issue":"2","key":"5134_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/apc.2014.0142","volume":"29","author":"JD Auerbach","year":"2015","unstructured":"Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2015;29(2):102\u201310.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"5134_CR22","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s40615-023-01729-9","volume":"11","author":"F Smit","year":"2024","unstructured":"Smit F, Masvawure TB. Barriers and Facilitators to Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) Among Black Women in the United States: a Systematic Review. J Racial Ethn Health Disparities. 2024;11(5):2649\u201362.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"7","key":"5134_CR23","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s10461-022-03960-7","volume":"27","author":"D Knight","year":"2023","unstructured":"Knight D, Saleem HT, Stockman JK, Willie TC. Experiences of Black Women in the United States Along the PrEP Care Continuum: A Scoping Review. AIDS Behav. 2023;27(7):2298\u2013316.","journal-title":"AIDS Behav"},{"issue":"41","key":"5134_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","volume":"19","author":"YA Huang","year":"2018","unstructured":"Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014\u20132016. MMWR Morb Mortal Wkly Rep. 2018;19(41):1147\u201350.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"5134_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10461-024-04491-z","volume":"29","author":"A Sims Haynes","year":"2025","unstructured":"Sims Haynes A, Markham C, Schick V, et al. A Systematic Review and Narrative Synthesis of Factors Affecting Pre-exposure Prophylaxis Willingness Among Black Women for HIV Prevention. AIDS Behav. 2025;29(1):101\u201332.","journal-title":"AIDS Behav"},{"key":"5134_CR26","unstructured":"AIDSVu. National PrEP-To-Need-Ratio. https:\/\/aidsvu.org\/resources\/#\/datasets"},{"issue":"1","key":"5134_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.whi.2019.08.001","volume":"30","author":"TC Willie","year":"2020","unstructured":"Willie TC, Keene DE, Kershaw TS, Stockman JK. You Never Know What Could Happen\": Women\u2019s Perspectives of Pre-Exposure Prophylaxis in the Context of Recent Intimate Partner Violence. Womens Health Issues. 2020;30(1):41\u20138.","journal-title":"Womens Health Issues"},{"issue":"8","key":"5134_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2023.14461","volume":"330","author":"UPST Force","year":"2023","unstructured":"Force UPST. Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;330(8):736\u201345.","journal-title":"JAMA"},{"key":"5134_CR29","volume":"18","author":"C Conley","year":"2022","unstructured":"Conley C, Johnson R, Bond K, Brem S, Salas J, Randolph S. US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review. Womens Health. 2022;18:17455057221103098.","journal-title":"Womens Health"},{"issue":"5","key":"5134_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000001950","volume":"15","author":"AS Patel","year":"2019","unstructured":"Patel AS, Goparaju L, Sales JM, et al. Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and Acceptability. J Acquir Immune Defic Syndr. 2019;15(5):527\u201332.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"5134_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1089\/apc.2018.0030","volume":"32","author":"DE Koren","year":"2018","unstructured":"Koren DE, Nichols JS, Simoncini GM. HIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics\/Gynecology Clinic. AIDS Patient Care STDS. 2018;32(12):490\u20134.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"5134_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/09540121.2020.1769834","volume":"33","author":"LM Hill","year":"2021","unstructured":"Hill LM, Lightfoot AF, Riggins L, Golin CE. Awareness of and attitudes toward pre-exposure prophylaxis among African American women living in low-income neighborhoods in a Southeastern city. AIDS Care. 2021;33(2):239\u201343.","journal-title":"AIDS Care"},{"key":"5134_CR33","unstructured":"Jones M, Leak L, Robinson S et al. Turning Darkness into Light: Residents of Public Housing Communities Explore Community Concerns through Photography to Inform HIV Prevention in Durham. Minority Health Conference. Chapel Hill, NC. 2018."},{"issue":"5","key":"5134_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/JNC.0000000000000189","volume":"31","author":"SD Randolph","year":"2020","unstructured":"Randolph SD, Golin C, Welgus H, Lightfoot AF, Harding CJ, Riggins LF. How perceived structural racism and discrimination and medical mistrust in the health system influences participation in HIV health services for Black women living in the United States South: a qualitative, descriptive study. J Assoc Nurses AIDS Care. 2020;31(5):598\u2013605.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"6","key":"5134_CR35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1177\/10901981221109138","volume":"49","author":"S Rimmler","year":"2022","unstructured":"Rimmler S, Golin C, Coleman J, et al. Structural Barriers to HIV Prevention and Services: Perspectives of African American Women in Low-Income Communities. Health Educ Behav. 2022;49(6):1022\u201332.","journal-title":"Health Educ Behav"},{"issue":"5","key":"5134_CR36","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s10461-019-02733-z","volume":"24","author":"JL Glick","year":"2020","unstructured":"Glick JL, Russo R, Jivapong B, et al. The PrEP Care Continuum Among Cisgender Women Who Sell Sex and\/or Use Drugs Globally: A Systematic Review. AIDS Behav. 2020;24(5):1312\u201333.","journal-title":"AIDS Behav"},{"issue":"4","key":"5134_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","volume":"16","author":"PS Sullivan","year":"2019","unstructured":"Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation strategies to increase PrEP uptake in the South. Curr HIV AIDS Rep. 2019;16(4):259\u201369.","journal-title":"Curr HIV AIDS Rep"},{"issue":"5","key":"5134_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/13691058.2020.1720297","volume":"23","author":"LA Nydegger","year":"2021","unstructured":"Nydegger LA, Dickson-Gomez J, Ko TK. Structural and syndemic barriers to PrEP adoption among Black women at high risk for HIV: a qualitative exploration. Cult Health Sex. 2021;23(5):659\u201373.","journal-title":"Cult Health Sex"},{"issue":"9","key":"5134_CR39","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2105\/AJPH.2019.305172","volume":"109","author":"AJ Siegler","year":"2019","unstructured":"Siegler AJ, Bratcher A, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health. 2019;109(9):1216\u201323.","journal-title":"Am J Public Health"},{"issue":"4","key":"5134_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1521\/aeap.2023.35.4.309","volume":"35","author":"AP Barnett","year":"2023","unstructured":"Barnett AP, Arnold T, Elwy AR, et al. Considerations for PrEP Implementation at Federally Qualified Health Centers in Mississippi: Perspectives From Staff and Patients. AIDS Educ Prev. 2023;35(4):309\u201319.","journal-title":"AIDS Educ Prev"},{"issue":"2","key":"5134_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65\u201376.","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"5134_CR42","doi-asserted-by":"publisher","first-page":"e0320093","DOI":"10.1371\/journal.pone.0320093","volume":"20","author":"LM Hill","year":"2025","unstructured":"Hill LM, Allison O, Adeniran O, et al. PrEP knowledge and perceptions among women living in North Carolina public housing communities. PLoS One. 2025;20(3):e0320093.","journal-title":"PLoS One"},{"key":"5134_CR43","unstructured":"North Carolina HIV\/STD\/Hepatitis Surveillance Unit. 2024 North Carolina HIV Surveillance Report. Raleigh, North Carolina.: Division of Public Health, Communicable Disease Branch. 2025."},{"issue":"5","key":"5134_CR44","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/s10461-021-03519-y","volume":"26","author":"MCD Stoner","year":"2022","unstructured":"Stoner MCD, Bhushan NL, Maragh-Bass AC, et al. Using Participatory Methods to Assess PrEP Interest and Uptake Among Young People Living in the Southeastern US: A Mixed Methods Assessment. AIDS Behav. 2022;26(5):1672\u201383.","journal-title":"AIDS Behav"},{"issue":"4","key":"5134_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1353\/cpr.2022.0076","volume":"16","author":"AC Maragh-Bass","year":"2022","unstructured":"Maragh-Bass AC, LeMasters K, Sanders T, et al. Lessons Learned in Centering Youth Voices in HIV Prevention: The Adolescent Health Working Group. Prog Community Health Partnersh. 2022;16(4):551\u201361.","journal-title":"Prog Community Health Partnersh"},{"issue":"6","key":"5134_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/apc.2016.0098","volume":"30","author":"A Braksmajer","year":"2016","unstructured":"Braksmajer A, Senn TE, McMahon J. The Potential of Pre-Exposure Prophylaxis for Women in Violent Relationships. AIDS Patient Care STDS. 2016;30(6):274\u201381.","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"5134_CR47","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s10461-017-1767-9","volume":"21","author":"T Willie","year":"2017","unstructured":"Willie T, Kershaw T, Campbell JC, Alexander KA. Intimate Partner Violence and PrEP Acceptability Among Low-Income, Young Black Women: Exploring the Mediating Role of Reproductive Coercion. AIDS Behav. 2017;21(8):2261\u20139.","journal-title":"AIDS Behav"},{"issue":"3 Suppl","key":"5134_CR48","first-page":"MS22","volume":"37","author":"RD Hays","year":"1999","unstructured":"Hays RD, Shaul JA, Williams VS, et al. Psychometric properties of the CAHPS 1.0 survey measures. Consumer Assessment of Health Plans Study. Med Care. 1999;37(3 Suppl):MS22\u201331.","journal-title":"Med Care"},{"issue":"2","key":"5134_CR49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1089\/pop.2021.0289","volume":"25","author":"A Coaston","year":"2022","unstructured":"Coaston A, Lee SJ, Johnson J, Hardy-Peterson M, Weiss S, Stephens C. Mobile Medical Clinics in the United States Post-Affordable Care Act: An Integrative Review. Popul Health Manag. 2022;25(2):264\u201379.","journal-title":"Popul Health Manag"},{"issue":"1","key":"5134_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12939-017-0671-2","volume":"5","author":"SWY Yu","year":"2017","unstructured":"Yu SWY, Hill C, Ricks ML, Bennet J, Oriol NE. The scope and impact of mobile health clinics in the United States: a literature review. Int J Equity Health. 2017;5(1):178.","journal-title":"Int J Equity Health"},{"issue":"6","key":"5134_CR51","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S2352-3018(23)00079-6","volume":"10","author":"JE Haberer","year":"2023","unstructured":"Haberer JE, Mujugira A, Mayer KH. The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities. Lancet HIV. 2023;10(6):e404\u201311.","journal-title":"Lancet HIV"},{"issue":"10","key":"5134_CR52","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/09564624241252457","volume":"35","author":"H Shi","year":"2024","unstructured":"Shi H, Du J, Jin G, et al. Effectiveness of eHealth interventions for HIV prevention, testing and management: An umbrella review. Int J STD AIDS. 2024;35(10):752\u201374.","journal-title":"Int J STD AIDS"},{"issue":"9","key":"5134_CR53","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s10461-024-04366-3","volume":"28","author":"S Bonett","year":"2024","unstructured":"Bonett S, Li Q, Sweeney A, Gaither-Hardy D, Safa H. Telehealth models for PrEP delivery: a systematic review of acceptability, implementation, and impact on the PrEP care continuum in the United States. AIDS Behav. 2024;28(9):2875\u201386.","journal-title":"AIDS Behav"},{"issue":"12","key":"5134_CR54","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1007\/s10461-022-03709-2","volume":"26","author":"JP Meyer","year":"2022","unstructured":"Meyer JP, Price CR, Ye Y, et al. A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks. AIDS Behav. 2022;26(12):3807\u201317.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05134-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:03:10Z","timestamp":1780671790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05134-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":54,"alternative-id":["5134"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05134-1","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"3 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Golin provided scientific consultation regarding medication adherence to Gilead Sciences, 3 years prior to the start of the study reported herein. Dr. McKellar has received separate grants from Gilead Sciences, which provide direct institutional support. No other authors have any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All study procedures were reviewed and approved by the institutional review boards of the University of North Carolina at Chapel Hill (IRB #22-1570) and Duke University (IRB Pro00110500). Post-visit client satisfaction surveys were conducted anonymously. To thank participants for their time, small gift bags containing self-care products (e.g. nail polish, hand cream) were offered.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}